About Us
The Genitourinary Malignancies Research Center focuses on advancing discoveries to better understand, diagnose and treat cancer of the prostate, bladder and kidney. The center is a cross-discipline partnership that will leverage Cleveland Clinic's research and clinical strengths to make practice-changing discoveries in GU cancers.
More About Us
Research News
Latest novel finding adds to list of cancers associated with the HSD3B1 gene; clinical and research teams investigating potential connections.
Dr. Nima Sharifi and a team of researchers uncovered how tumors circumvent prostate cancer therapy and identified a potential window of time after treatment when tumors may be responsive to immunotherapy.
Dr. Sharifi and a team of respiratory and prostate cancer researchers studied how a male sex hormone involved in prostate cancer may provide clues to why men are more likely to develop COVID-19 and have poorer disease-related outcomes than women.